Cite

HARVARD Citation

    Hewison, C. et al. (2022). Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort . Clinical infectious diseases. pp. 1006-1013. [Online]. 
  
Back to record